Enanta Pharmaceuticals Is A Clinical Stage Biotechnology Company Based In Watertownmassachusettsfounded In 1995The Company Focuses On Discovering And Developing Small Molecule Therapeutics For Viral And Immune Mediated Diseaseswith A Team Of Approximately 125 Employeesenanta Has A Market Capitalization Of Around $280 Million The Company Specializes In Innovative Chemistry To Create Differentiated Drugsparticularly In The Area Of Protease And Core Protein Inhibitorsenanta Has Made Significant Contributions To The Treatment Of Hepatitis Cwith Therapies That Have Led To Over One Million Cures Worldwideincluding The Protease Inhibitor Glecaprevirtheir Pipeline Includes Promising Candidates For Hepatitis Brespiratory Syncytial Virusand Covid 19Enanta Collaborates With Notable Partners Like Abbvie And Novartis To Enhance Its Drug Development Efforts And Advance Clinical Trialsthe Company Is Dedicated To Addressing Global Health Challenges Through Its Targeted Drug Development Initiatives
